Genetically determined ABCB5 functionality correlates with pigmentation phenotype and melanoma risk

Biochemical and Biophysical Research Communications

Volumn 436, Issue 3, 2013, Pages 536-542

  Lin, Jennifer Y ^a   Zhang, Mingfeng ^a   Schatton, Tobias ^a   Wilson, Brian J ^a,b   Alloo, Allireza ^a,b   Ma, Jie ^a,b   Qureshi, Abrar A ^a   Frank, Natasha Y ^a,c   Han, Jiali ^a   Frank, Markus H ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

ABCB5; Cancer; Cancer stem cells; Case controlled study; Genotype; Humans; Melanoma; Pigmentation; Single nucleotide polymorphism

Indexed keywords

ABCB5 PROTEIN; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CANCER SURVIVAL; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HAIR COLOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOGENESIS; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GROWTH;

ABCB5; CANCER; CANCER STEM CELLS; CASE-CONTROLLED STUDY; GENOTYPE; HUMANS; MELANOMA; PIGMENTATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; HAIR COLOR; HUMANS; MALE; MELANINS; MELANOMA; MIDDLE AGED; ODDS RATIO; P-GLYCOPROTEIN; PHENOTYPE; PIGMENTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84879879048     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.006     Document Type: Article

References (25)

1. Schatton T., Frank M.H. Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res. 2008, 21:39-55.
2. Yeh I., Bastian B.C. Genome-wide associations studies for melanoma and nevi. Pigment Cell Melanoma Res. 2009, 22:527-528.
3. Lin J.Y., Fisher D.E. Melanocyte biology and skin pigmentation. Nature 2007, 445:843-850.
4. Frank N.Y., Pendse S.S., Lapchak P.H., Margaryan A., Shlain D., Doeing C., Sayegh M.H., Frank M.H. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J. Biol. Chem. 2003, 278:47156-47165.
5. Schatton T., Murphy G.F., Frank N.Y., Yamaura K., Waaga-Gasser A.M., Gasser M., Zhan Q., Jordan S., Duncan L.M., Weishaupt C., Fuhlbrigge R.C., Kupper T.S., Sayegh M.H., Frank M.H. Identification of cells initiating human melanomas. Nature 2008, 451:345-349.
6. Setia N., Abbas O., Sousa Y., Garb J.L., Mahalingam M. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma. Mod. Pathol. 2012, 25:1169-1175.
7. Frank N.Y., Schatton T., Kim S., Zhan Q., Wilson B.J., Ma J., Saab K.R., Osherov V., Widlund H.R., Gasser M., Waaga-Gasser A.M., Kupper T.S., Murphy G.F., Frank M.H. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res. 2011, 71:1474-1485.
8. Kupas V., Weishaupt C., Siepmann D., Kaserer M.L., Eickelmann M., Metze D., Luger T.A., Beissert S., Loser K. RANK is expressed in metastatic melanoma and highly upregulated on melanoma-initiating cells. J. Invest. Dermatol. 2011, 131:944-955.
9. Linley A.J., Mathieu M.G., Miles A.K., Rees R.C., McArdle S.E., Regad T. The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo. J. Biol. Chem. 2012, 287:13633-13643.
10. Ma J., Lin J.Y., Alloo A., Wilson B.J., Schatton T., Zhan Q., Murphy G.F., Waaga-Gasser A.M., Gasser M., Stephen Hodi F., Frank N.Y., Frank M.H. Isolation of tumorigenic circulating melanoma cells. Biochem. Biophys. Res. Commun. 2010, 402:711-717.
11. Schatton T., Schutte U., Frank N.Y., Zhan Q., Hoerning A., Robles S.C., Zhou J., Hodi F.S., Spagnoli G.C., Murphy G.F., Frank M.H. Modulation of T-cell activation by malignant melanoma initiating cells. Cancer Res. 2010, 70:697-708.
12. Chartrain M., Riond J., Stennevin A., Vandenberghe I., Gomes B., Lamant L., Meyer N., Gairin J.E., Guilbaud N., Annereau J.P. Melanoma chemotherapy leads to the selection of ABCB5-expressing cells. PLoS ONE 2012, 7:e36762.
13. Reid A.L., Millward M., Pearce R., Lee M., Frank M.H., Ireland A., Monshizadeh L., Rai T., Heenan P., Medic S., Kumarasinghe P., Ziman M. Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression. Br. J. Dermatol. 2013, 168:85-92.
14. Frank N.Y., Margaryan A., Huang Y., Schatton T., Waaga-Gasser A.M., Gasser M., Sayegh M.H., Sadee W., Frank M.H. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res. 2005, 65:4320-4333.
15. Huang Y., Anderle P., Bussey K.J., Barbacioru C., Shankavaram U., Dai Z., Reinhold W.C., Papp A., Weinstein J.N., Sadee W. Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res. 2004, 64:4294-4301.
16. Wilson B.J., Schatton T., Zhan Q., Gasser M., Ma J., Saab K.R., Schanche R., Waaga-Gasser A.M., Gold J.S., Huang Q., Murphy G.F., Frank M.H., Frank N.Y. ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients. Cancer Res. 2011, 71:5307-5316.
17. Moitra K., Scally M., McGee K., Lancaster G., Gold B., Dean M. Molecular evolutionary analysis of ABCB5: the ancestral gene is a full transporter with potentially deleterious single nucleotide polymorphisms. PLoS ONE 2011, 6:e16318.
18. Dausset J., Cann H., Cohen D., Lathrop M., Lalouel J.M., White R. Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics 1990, 6:575-577.
19. Carlson C.S., Eberle M.A., Rieder M.J., Yi Q., Kruglyak L., Nickerson D.A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 2004, 74:106-120.
20. Stram D.O., Leigh Pearce C., Bretsky P., Freedman M., Hirschhorn J.N., Altshuler D., Kolonel L.N., Henderson B.E., Thomas D.C. Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum. Hered. 2003, 55:179-190.
21. Pan T., Zhu J., Hwu W.J., Jankovic J. The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells. PLoS ONE 2012, 7:e45183.
22. Nan H., Kraft P., Hunter D.J., Han J. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Int. J. Cancer 2009, 125:909-917.
23. Izawa A., Schatton T., Frank N.Y., Ueno T., Yamaura K., Pendse S.S., Margaryan A., Grimm M., Gasser M., Waaga-Gasser A.M., Sayegh M.H., Frank M.H. A novel in vivo regulatory role of P-glycoprotein in alloimmunity. Biochem. Biophys. Res. Commun. 2010, 394:646-652.
24. Frank N.Y., Schatton T., Frank M.H. The therapeutic promise of the cancer stem cell concept. J. Clin. Invest. 2010, 120:41-50.
25. Cheung S.T., Cheung P.F., Cheng C.K., Wong N.C., Fan S.T. Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance. Gastroenterology 2011, 140:344-355.